Mechanism and Efficacy of Sub-50-Nm Tenfibgen Nanocapsules for Cancer Cell-Directed Delivery of Anti-Ck2 RNAi to Primary and Metastatic Squamous Cell Carcinoma
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-14-0166
Full Text
Open PDFAbstract
Available in full text
Date
May 27, 2014
Authors
Publisher
American Association for Cancer Research (AACR)